Current NDC auxiliary source row compounder:3497

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 70092-148
Product Ndc: 70092-148
Product Ndc Digits: 70092148
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Sodium Citrate 4% 3 ml syr
Proprietary Name Suffix: [empty]
Nonproprietary Name: Sodium Citrate 4% 3 ml syr
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: QuVa Pharma, Inc.
Establishment Name: QuVa Pharma, Inc.
Establishment Fei: [empty]
Substance Name: TRISODIUM CITRATE DIHYDRATE
Active Ingredients Info: 120 mg/3 mL
History Active Ingredients Raw: TRISODIUM CITRATE DIHYDRATE
History Active Ingredients Info Raw: 120 mg/3 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 70092-148-43
Package Ndc: 70092-148-43
Package Ndc Digits: 7009214843
Package Ndc11: 70092014843
Package Description: 3 mL in 1 SYRINGE (70092-148-43)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3497
Source Row Number: 3497
Source Row Hash: 176a245b1b28b02f520ecadf1903b8d3078f591bec65e83d28ead3d8f313ac2d
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "70092-148",
    "DEASCHEDULE": "",
    "LABELERNAME": "QuVa Pharma, Inc.",
    "SUBSTANCENAME": "TRISODIUM CITRATE DIHYDRATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "70092-148-43",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Sodium Citrate 4% 3 ml syr",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Sodium Citrate 4% 3 ml syr",
    "PACKAGEDESCRIPTION": "3 mL in 1 SYRINGE (70092-148-43) ",
    "ACTIVEINGREDIENTSINFO": "120 mg/3 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3497
Source Row Number: 3497
Status Scope: package
Lookup Ndc: 70092-148-43
Lookup Ndc Digits: 7009214843
Product Ndc: 70092-148
Product Ndc Digits: 70092148
Package Ndc: 70092-148-43
Package Ndc Digits: 7009214843
Package Ndc11: 70092014843
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 176a245b1b28b02f520ecadf1903b8d3078f591bec65e83d28ead3d8f313ac2d
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27